945856-58-6

Basic information

• Product Name: C₁₇H₁₅ClN₆OS
• CAS NO: 945856-58-6
• Molecular Weight: 386.865
• Mol File: 945856-58-6.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: C₁₇H₁₅ClN₆OS(CAS DataBase Reference)
• NIST Chemistry Reference: C₁₇H₁₅ClN₆OS(945856-58-6)
• EPA Substance Registry System: C₁₇H₁₅ClN₆OS(945856-58-6)

Safety Data

• Hazardous Substances Data: 945856-58-6(Hazardous Substances Data)

Upstream product

• 175137-17-4 1-(4-Chloro-phenyl)-5-propyl-1H-pyrazole-4-carboxylic acid 
• 75423-15-3 4-methyl-4,5-dihydro-1,2,3-thiadiazole-5-carbohydrazide 

Relevant articles and documents

Synthesis and biological activity evaluation of 1,2,3-thiadiazole derivatives as potential elicitors with highly systemic acquired resistance

Elicitors provide a broad spectrum of systemic acquired resistance by altering the physical and physiological status of the host plants and, therefore, are among the most successful directions in modern pesticide development for plant protection. To develop a novel elicitor with highly systemic acquired resistance, two series of thiazole- and oxadiazole-containing thiadiazole derivatives were rationally designed and synthesized according to the principle of combination of bioactive substructures in this work. Their structures were characterized by 1H nuclear magnetic resonance (NMR), infrared (IR), high-resolution mass spectrometry (HRMS), or elemental analysis. Their potential systemic acquired resistance as an elicitor was also evaluated; bioassay results indicated that, among the 23 compounds synthesized, three compounds, 10a, 10d, and 12b, displayed better systemic acquired resistance than the positive control, tiadinil, a commercialized 1,2,3-thiadiazolebased elicitor. In addition, three other compounds, 10f, 12c, and 12j, exhibited a certain degree of fungus growth inhibition In vitro or In vivo. Our results demonstrated that, in combination of bioactive substructures is an interesting exploration for novel pesticide development, thiazole-and oxadiazole-containing thiadiazole derivatives are potential elicitors with good systemic acquired resistance.